Intervention Study on Digital Health Management

Launched by SHANGHAI 10TH PEOPLE'S HOSPITAL · Apr 21, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a new digital health system designed to help people with certain heart and metabolic conditions, specifically hypertension (high blood pressure) and high cholesterol. The goal is to create a personalized program that closely monitors patients' health using wearable devices. These devices will track important health indicators like blood pressure, blood sugar, and cholesterol levels. By analyzing individual risk factors such as genetics, lifestyle, and emotional well-being, the study aims to provide tailored recommendations for improving health and reducing the risk of serious heart-related issues.

To participate in this trial, you need to be between 18 and 65 years old and meet certain health criteria, such as having mild high blood pressure or high cholesterol, but you shouldn't be on any medications for these conditions yet. Participants will use a smartphone to access the digital system and can expect to receive continuous support and feedback on their health. It's important to know that individuals with more severe health issues, like heart disease or certain cancers, won't be eligible to join. This study represents a promising step towards more effective and personalized management of chronic health problems.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:1. Age 18-65 years old; 2. Meet one of the following three conditions:
• • 1. Diastolic hypertension (systolic blood pressure \< 140 MMHG and diastolic blood pressure ≥90mmHg)
• • 2. Glycosylated hemoglobin (6.0-6.5)
• • 3. Obesity (BMI≥28kg/m²)
• • 4. Mild hyperlipemia: total cholesterol (TC) ≥5.2 mmol/L and \< 6.2 mmol/L, or low-density lipoprotein cholesterol (LDL-C) ≥3.4 mmol/L and \< 4.1 mmol/L 3. Antihypertensive or lipid-lowering medications have not been started 4. Use a smartphone and volunteer
• Exclusion Criteria:
• • 1. Complicated with chronic liver and kidney disease, coronary heart disease, heart failure and severe valvular disease
• • 2. Previous cardiovascular and cerebrovascular events
• • 3. Diastolic blood pressure ≥99mmHg
• • 4. Glycated hemoglobin ≥6.5
• • 5. Other life expectancy such as cancer is less than 5 years
• • 6. Participate in other clinical trials